The Myricaceae plant Myrica rubra SIEB. et ZUCC. is widely distributed in China, Taiwan, Japan and Korea. The bark of M. rubra (Myricae cortex) has been used locally as an astringent, antidote, and antidiarrheic in Japanese folk medicine, and has also been used externally for burns and skin diseases in Chinese traditional medicine. Previously, several flavonoids, 2) tannins, 2) triterpenes, 3) and diarylheptanoids [4][5][6] [7] [8] were isolated from the bark of M. rubra. Pharmacological studies of this natural medicine have reported that its methanolic extract showed protective effects on CCl 4
50% aqueous ethanolic extract and some constituents inhibited melanin biosynthesis 10) and showed anti-androgenic activity. 11) In the course of characterization studies on the bioactive constituents of Chinese natural medicines, 1,12) we have isolated three new diarylheptanoid glycosides, termed (ϩ) . In addition, we describe the inhibitory effect of components isolated from the bark of M. rubra on an immediate allergic reaction by monitoring the release of b-hexosaminidase from rat basophilic leukemia (RBL-2H3) cells.
Isolation of Chemical Constituents from the Dried Bark of M. rubra The methanolic extract of the bark of M. rubra (cultivated in Guang Dong province, China) was suspended in MeOH and filtered by Kiriyama funnel to give a soluble fraction and insoluble residue, which was recrystallized with aqueous MeOH to furnish myricitrin (15, 4 .6% from natural medicine). The soluble fraction was partitioned in an n-BuOH-H 2 O (1 : 1) mixture to give an n-BuOH-soluble fraction and H 2 O-soluble fraction. The n-BuOH-soluble fraction was subjected to ordinary-and reversed-phase silica gel column chromatography, and finally HPLC, to furnish with twenty known compounds, myricanol (4, 4,5) 0.73%), myricanol glucoside (5, 4) 0.20%), myricanone (6, 4,5) 0.036%), ursolic acid (7, 13) 0.027%), acetylursolic acid (8, 13) 0.0021%), ursonic acid (9, 13) 0.0067%), rhoiptelenol (10, 14) 0.0036%), taraxerol (11, 3) 0.014%), myricadiol (12, 3) 0.020%), maslinic acid (13, 6, 15) ϭcrategolic acid, 0.00083%), alphitolic acid (14, 6) 0.0014%), myricitrin (15, 2, 10) 5.59%), myricetin (16, 2, 10) 0.027%), quercitrin (17, 16) 0.0028%), 18 17) (0.0059%), (Ϫ)-epigallocatechin (19, 18) 0.0066%), (Ϫ)-epigallocatechin 3-Ogallate (20, 18) 0.043%), 3,5-dimethoxy-4-hydroxyphenol 1-Ob-D-(6Ј-O-galloyl)glucopyranoside (21, 19) 0.012%), b-sitos- Ϫ respectively, in addition to a fragment ion peak at m/z 357 (MϪC 6 H 11 O 5 ) was determined from quasimolecular ion peaks and by highresolution MS measurement. In the UV spectrum of 1, absorption maxima were observed at 216 (log e 4.5), 256 (4.2), and 299 (3.7) nm, which were suggestive of a biphenyl type diarylheptanoid structure.
8) The IR spectrum of 1 showed absorption bands at 3568, 1598, 1560, 1508, and 1073 cm Ϫ1 , ascribable to hydroxyl, benzene ring, and ether functions. On acid hydrolysis with 5% aqueous sulfuric acid (H 2 SO 4 )-1,4-dioxane (1 : 1, v/v), 1 liberated D-glucose, which was identified by GLC analysis of the trimethylsilyl thiazolidine derivative. 21 (7, 8, 9 , 10, 12, 13-H 2 ), which were very similar to those of myricanol glucoside (5).
The planar structure of 1, including the positions of two methoxyl groups and a glycosidic linkage, which was the same as that 5, was constructed on the basis of 1 H-1 H correlation spectroscopy (H-H COSY) and heteronuclear multiple bond correlation (HMBC) experiments. And the H-H COSY experiment on 1 indicated the presence of two partial structures written in the bold line, whereas, in the HMBC experiment, long-range correlations were observed between the protons and carbons, as shown in Fig. 1 . Enzymatic hydrolysis of 1 with b-glucosidase liberated (ϩ)-S-myricanol (1a). The proton and carbon signals in the 1 H-NMR (CDCl 3 ) and 13 C-NMR (Table 1) In order to confirm the absolute stereostructure of 1a, we carried out an application of the modified Mosher's method, 22) as shown in Fig. 1 . Thus, diazomethane methylation of 1a furnished the dimethylated-derivative (1b), which was subjected to the modified Mosher's method for the 11-mono-(R)- . Consequently, the absolute stereostructure at the 11-positions of 1 and 1a have been determined to be S. Previously, a (Ϯ)-myricanol mixture was isolated from the bark of Myrica cerifera, and its structure was established by crystal X-ray analysis. 23) This paper is the first report for the (ϩ)-form of myricanol. 13 C-NMR (Table 1 ) spectra of 3 were found to be similar to those of 2, except for signals due to an olefin function. New aglycons, myricanenes A (2a) and B (3a), were obtained by enzymatic hydrolysis of 2 and 3 with naringinase, respectively. On the other hand, dehydration of myricanol (4) with thionyl chloride (SOCl 2 ) yielded 2a and 3a, so that the structures of 2a and 3a were determined to be as shown in Fig. 2 . The structure of the disaccharide moiety and the position of the glycosidic linkage in 2 and 3 were elucidated by HMBC experiment. Namely, long-range correlations were observed between the 1Ј-proton of the glucopyranosyl moiety and the 5-carbon of the aglycon moiety, and between the 1Љ-proton of the arabinofuranosyl moiety and the 6Ј-carbon of the glucopyranosyl moiety. Consequently, the stereostructures of 2 and 3 were elucidated as shown.
Stereostructures of Myricanene
Inhibitory Effect of Constituents from M. rubra on the Release of b b-Hexosaminidase from RBL-2H3 Cells Histamine, which is released from mast cells stimulated by an antigen or a degranulation inducer, is usually determined as a degranulation marker in in vitro experiments on immediate allergic reactions. b-Hexosaminidase is also stored in secretory granules of mast cells, and is also released concomitantly with histamine when mast cells are immunologically activated.
24) Therefore, it is generally accepted that b-hexosaminidase is a degranulation marker of mast cells. Previously, we reported the isolation and structural elucidation of various antiallergic constituents from natural medicines, such as Hydrangea macrophylla var. thunbergii, 25) Hovenia dulcis, 26) Rhodiola quadrifida, 27) R. sacra, 28) Alisma orientale, 29) Kochia scoparia, 30) Corchorus olitorius, 31) Phaseolus vulgaris, 32) Zizyphus jujuba var. spinosa, 33) and Benincasa hispida. 34) In our continuous search for antiallergic principles from natural sources, we examined the effects of constituents from the bark of M. rubra on the release of b-hexosaminidase induced by dinitrophenylated bovine serum albumine (DNP-BSA) from RBL-2H3 cells sensitized with anti-DNP IgE. As shown in Table 2 , biphenyl type diarylheptanoids, (ϩ)-S-myricanol (1a, IC 50 ϭ28 mM), myricanenes A (2a, 98 mM) and B (3a, ca. 100 mM), myricanol (4, 63 mM), myricanone (6, 46 mM), and a flavonoid, myricetin (16, 23 mM), showed strong activity. On the other hand, biphenyl type diarylheptanoid glycosides (1-3, 5), flavonoid glycosides (15, 18) , and catechins (19, 20) exhibited weak inhibition. In addition, the effects of test compounds on b-hexosaminidase activity were examined to clarify whether their effects were due to the inhibition of enzyme activity or of degranulation. As a result, these active constituents (1a, 2a, 3a, 4, 6, 16) did not affect the enzyme activity of b-hexosaminidase. Previously, a diarylheptanoid, curcumin, and a few flavonoids such as myricetin were reported to inhibit the degranulation, 35) but this is the first report of the degranulation inhibitory activity of biphenyl type diarylheptanoids.
Experimental
The following instruments were used to obtain physical data: specific rotations, Horiba SEPA-300 digital polarimeter (lϭ5 cm); UV spectra, Shimadzu UV-1600 spectrometer; IR spectra, Shimadzu FTIR-8100 spectrometer; electron impact (EI)-MS and high-resolution MS, JEOL JMS-GCMATE mass spectrometer; FAB-MS and high-resolution MS, JEOL JMS-SX 102A mass spectrometer; 1 H-NMR spectra, JNM-LA500 (500 MHz) spectrometer; 13 C-NMR spectra, JNM-LA500 (125 MHz) spectrometer with tetramethylsilane as an internal standard; HPLC detector, Shimadzu RID-6A refractive index detector and Shimadzu SPD-10A UV-VIS detector.
The following experimental conditions were used for chromatography: ordinary-phase silica gel column chromatography, Silica gel BW-200 (Fuji Silysia Chemical, Ltd., 150-350 mesh); reversed-phase silica gel column chromatography, Chromatorex ODS DM1020T (Fuji Silysia Chemical, Ltd., 100-200 mesh); TLC, pre-coated TLC plates with Silica gel 60F 254 (Merck, 0.25 mm) (ordinary phase) and Silica gel RP-18 F 254S (Merck, 0.25 mm) (reversed phase); reversed-phase high performance thin-layer chromatography (HPTLC), pre-coated TLC plates with Silica gel RP-18 WF 254S (Merck, 0.25 mm); detection was achieved by spraying with 1% Ce(SO 4 ) 2 -10% aqueous H 2 SO 4 followed by heating.
Extraction and Isolation The dried bark of Myrica rubra (5.0 kg, cultivated in Guang Dong, China and purchased from MAE CHU Co., Ltd., Nara, Japan) was finely cut and extracted three times with MeOH at room temperature for 1 d. Evaporation of the solvent under reduced pressure provided a MeOH extract (1600 g). The MeOH extract (1400 g) was suspended in a small amount of MeOH, and the suspension was filtered to give a soluble fraction (1200 g) and an insoluble fraction, which was recrystallized with aqueous MeOH to furnish myricitrin (15, 200 g ). The soluble fraction (722 g) was partitioned in an n-BuOH-H 2 O (1 : 1) mixture to give n-BuOHand H 2 O-soluble fractions (380 g and 342 g), respectively. The n-BuOH-soluble fraction (50 g) was subjected to ordinary-phase silica gel column chromatography [1.5 kg, Through a similar procedure, a solution of 2 or 3 (3.0 mg each, 0.005 mmol) in 0.2 M acetate buffer (pH 4.0, 2.0 ml) was treated with naringinase (10 mg, from Penicillium decumbens, Sigma Co., Ltd.), and the solution was stirred at 40°C for 4 d, respectively. After treatment of the reaction mixture with EtOH, the mixture was evaporated to dryness under reduced pressure, and the residue was purified by ordinary-phase silica gel column chromatography [500 mg, n-hexane-AcOEt (3 : 1)] to give myricanenes A (2a, 1.0 mg, 62%) or B (3a, 1.0 mg, 62%). , and the whole mixture was stirred at room temperature for 30 min under N 2 atmosphere. The reaction mixture was poured into ice-water and the whole was extracted with AcOEt. The AcOEt extract was washed with saturated aqueous NaHCO 3 and brine, then dried over MgSO 4 powder and filtered. Removal of the solvent from the filtrate under reduced pressure furnished a residue, which was then purified by silica gel column chromatography [500 mg, n-hexane-AcOEt (4 : 1)] to give 6 (3.0 mg, 75%).
Diazomethane Methylation of 1a A solution of 1a (4.0 mg, 0.011 mmol) in MeOH (1.0 ml) was treated with CH 2 N 2 · Et 2 O (ca. 5 ml), and the whole mixture was stirred at room temperature for 30 min. Removal of the solvent under reduced pressure gave 1b (4.3 mg, quant. 
Preparation of the (R)-MTPA Ester (1c) and (S)-MTPA Ester (1d)
from 1b A solution of 1b (1.0 mg, 0.029 mmol) in CH 2 Cl 2 (1.0 ml) was treated with (R)-2-methoxy-2-trifluoromethylphenylacetic acid [(R)-MTPA] (6.6 mg, 0.028 mmol) in the presence of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC · HCl, 5.5 mg, 0.028 mmol) and 4-dimethylaminopyridine (4-DMAP, 2.0 mg, 0.016 mmol), and the mixture was heated under reflux for 6 h. After cooling, it was poured into ice-water and the whole was extracted with AcOEt. The AcOEt extract was successively washed with 5% aqueous HCl, saturated aqueous NaHCO 3 and brine, then dried over MgSO 4 powder and filtered. Removal of the solvent from the filtrate under reduced pressure furnished a residue which was purified by silica gel column chromatography [500 mg, n-hexane-AcOEt (2 : 1)] to give 1c (1.0 mg, 69%). Through a similar procedure, 1d (1.0 mg, 69%) was prepared from 1b (1.0 mg, 0.029 mmol) using (S)-2-methoxy-2-trifluoromethylphenylacetic acid [(S)-MTPA] (6.6 mg, 0.028 mmol), EDC · HCl (5.5 mg, 0.028 mmol) and 4-DMAP (2.0 mg, 0.016 mmol).
1c Dehydration of 4 A solution of 4 (50.0 mg, 0.014 mmol) in pryidine (2.0 ml) was treated with SOCl 2 (500 ml), and the mixture was stirred at 0°C for 1 h. The reaction mixture was poured into ice-water and the whole was extracted with AcOEt. The AcOEt extract was washed with saturated aqueous NaHCO 3 and brine, then dried over MgSO 4 powder and filtrated. Removal of the solvent from the filtrate under reduced pressure gave a residue. Acid Hydrolysis of 1-3 A solution of 1-3 (2 mg each) in 5% aqueous H 2 SO 4 -1,4-dioxane (0.5 ml, 1 : 1, v/v) was heated under reflux for 1 h. After cooling, the reaction mixture was neutralized with Amberlite IRA-400 (OH Ϫ form), and the residue was removed by filtration. After removal of the solvent from the filtrate under reduced pressure, the residue was transferred to a Sep-Pak C18 cartridge with H 2 O and MeOH. The H 2 O eluate was concentrated and the residue was treated with L-cysteine methyl ester hydrochloride (4 mg) in pyridine (0.5 ml) at 60°C for 1 h. After reaction, the solution was treated with N,O-bis(trimethylsilyl)trifluoroacetamide (0.2 ml) at 60°C for 1 h. The supernatant was then subjected to GLC analysis to identify the derivatives of D-glucose (i) from 1-3; and of L-arabinose (ii) from 2 and 3. GLC conditions: column: Supeluco STBTM-1, 30 mϫ0.25 mm (i.d.) capillary column; injector temperature: 230°C; detector temperature: 230°C; column temperature: 230°C; He flow rate: 15 ml/min; t R : i: 24.2 min, ii: 15.1 min.
Bioassay
Inhibitory Effect on the Release of b b-Hexosaminidase from RBL-2H3 Cells Inhibitory effects of test samples on the release of b-hexosaminidase from RBL-2H3 cells were evaluated by the following procedure. 36) RBL-2H3 cells were grown in Minimum Essential Medium Eagle (MEM, Shigma Co., Ltd.) containing fetal calf serum (10%), penicillin (100 units/ml), and streptomycin (100 mg/ml). Before the experiment, cells were dispensed into 24-well plates at the concentration of 2ϫ10 5 cells/well using a medium containing 0.45 mg/ml of anti-DNP IgE, and these were incubated overnight at 37°C in 5% CO 2 for sensitization of the cells. Then, cells were washed twice with 500 ml of siraganian buffer [119 mM NaCl, 5 mM KCl, 0.4 mM MgCl 2 , 25 mM piperazine-N,NЈ-bis(2-ethanesulfonic acid) (PIPES), 40 mM NaOH, pH 7.2] and incubated in 160 ml of siraganian buffer (5.6 mM glucose, 1 mM CaCl 2 , 0.1% BSA were added) for an additional 10 min at 37°C. Then, 20 ml of test sample solution was added to each well and incubated for 10 min, followed by the addition of 20 ml of antigen (DNP-BSA, final concentration was 10 mg/ml) at 37°C for 10 min to stimulate the cells to evoke allergic reactions (degranulation). The reaction was stopped by cooling in an ice bath for 10 min. Supernatant (50 ml) was transferred into a 96-well microplate and incubated with 50 ml of substrate (1 mM p-nitrophenyl-Nacetyl-b-D-glucosaminide) in 0.1 M citrate buffer (pH 4.5) at 37°C for 1 h. The reaction was stopped by adding 200 ml of stop solution (0.1 M Na 2 CO 3 /NaHCO 3 , pH 10.0). The absorbance was measured by a microplate reader at 405 nm. The test sample was dissolved in dimethylsulfoxide (DMSO), and the solution was added to siraganian buffer (final DMSO concentration was 0.1%).
For estimating the spontaneous release of b-hexosaminidase from cells, exactly the same procedure was followed (Normal), but without adding antigen and IgE. Blank absorbance of the test material was measured to eliminate interference caused by the color of the test material itself. For this, only test material and substrate were added without adding cell extract (Blank). Thus, the inhibition % of the release of b-hexosaminidase by the test material was calculated by the following equation.
Control (C): antigen-IgE response was evoked without test sample; Test (T): antigen-IgE response was evoked in the presence of test sample; Blank (B): only test sample and substrate were added; Normal (N): antigen-IgE response was not evoked, test sample was not added.
In this condition, it was calculated that 40-50% of b-hexosaminidase was released from the cells in the control groups by determination of the total b-hexosaminidase activity after sonication of the cell suspension.
b b-Hexosaminidase Inhibitory Activity The cell suspension (5ϫ10 7 cells) in 6 ml of PBS was sonicated. The solution was then centrifuged and the supernatant was diluted with siraganian buffer and adjusted to equal the enzyme activity of the degranulation test described above. The enzyme solution (45 ml) and test sample solution (5 ml) were transferred into a 96-well microplate and incubated with 50 ml of the substrate solution at 37°C for 1 h. The reaction was stopped by adding 200 ml of the stop solution. The absorbance was measured by a microplate reader at 405 nm.
Statistics Values were expressed as meansϮS.E.M. One-way analysis of variance following Dunnett's test was used for statistical analysis. 
